These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 609193)

  • 1. A controlled trial of nondrolone decanoate in the treatment of uremic anemia.
    Cattran DC; Fenton SS; Wilson DR; Oreopoulos D; Shimizu A; Richardson RM
    Kidney Int; 1977 Dec; 12(6):430-7. PubMed ID: 609193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of uremic patients to nandrolone decanoate.
    Doane BD; Fried W; Schwartz F
    Arch Intern Med; 1975 Jul; 135(7):972-5. PubMed ID: 1156056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nandrolone decanoate therapy for patients receiving hemodialysis. A controlled study.
    Williams JS; Stein JH; Ferris TF
    Arch Intern Med; 1974 Aug; 134(2):289-92. PubMed ID: 4602048
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of nandrolone decanoate as an adjuvant for erythropoietin dose reduction in treating anemia in patients on hemodialysis.
    Sheashaa H; Abdel-Razek W; El-Husseini A; Selim A; Hassan N; Abbas T; El-Askalani H; Sobh M
    Nephron Clin Pract; 2005; 99(4):c102-6. PubMed ID: 15703460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized prospective comparison between erythropoietin and androgens in CAPD patients.
    Navarro JF; Mora C; Macía M; García J
    Kidney Int; 2002 Apr; 61(4):1537-44. PubMed ID: 11918762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis.
    Berns JS; Rudnick MR; Cohen RM
    Clin Nephrol; 1992 May; 37(5):264-7. PubMed ID: 1606777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nandrolone decanoate on the anemia of chronic hemodialysis patients.
    Buchwald D; Argyres S; Easterling RE; Oelshlegel FJ; Brewer GJ; Schoomaker EB; Abbrecht PH; Williams GW; Weller JM
    Nephron; 1977; 18(4):232-8. PubMed ID: 323739
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of nandrolone decanoate on nutritional parameters in hemodialysis patients.
    Barton Pai A; Chretien C; Lau AH
    Clin Nephrol; 2002 Jul; 58(1):38-46. PubMed ID: 12141405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of nandrolone decanoate in patients with end stage renal disease in the erythropoietin era.
    Johansen KL
    Int J Artif Organs; 2001 Apr; 24(4):183-5. PubMed ID: 11394696
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of androgens for anemia in patients on hemodialysis.
    Neff MS; Goldberg J; Slifkin RF; Eiser AR; Calamia V; Kaplan M; Baez A; Gupta S; Mattoo N
    N Engl J Med; 1981 Apr; 304(15):871-5. PubMed ID: 7010161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of adjuvant androgen on anemia and nutritional parameters in chronic hemodialysis patients using low-dose recombinant human erythropoietin.
    Lee MS; Ahn SH; Song JH
    Korean J Intern Med; 2002 Sep; 17(3):167-73. PubMed ID: 12298427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis.
    Hendler ED; Goffinet JA; Ross S; Longnecker RE; Bakovic V
    N Engl J Med; 1974 Nov; 291(20):1046-51. PubMed ID: 4606387
    [No Abstract]   [Full Text] [Related]  

  • 13. Relative contributions of body iron status and uremia severity to anemia in patients with advanced chronic renal failure.
    Ifudu O; Dawood M; Friedman EA
    Nephron; 1997; 77(3):315-8. PubMed ID: 9375826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of androgen therapy on prostatic markers in hemodialyzed patients.
    Teruel JL; Aguilera A; Avila C; Ortuño J
    Scand J Urol Nephrol; 1996 Apr; 30(2):129-31. PubMed ID: 8738058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective controlled study of androgen therapy in the anemia of chronic renal disease: effects on iron kinetics.
    Solomon LR; Hendler ED
    Acta Haematol; 1988; 79(1):12-9. PubMed ID: 3124456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgens for the treatment of anemia in peritoneal dialysis patients.
    Navarro JF; Mora-Fernández C; Rivero A; Macía M; Gallego E; Chahin J; Méndez ML; García J
    Adv Perit Dial; 1998; 14():232-5. PubMed ID: 10649731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nandrolone decanoate therapy for anemia in patients on haemodialysis.
    Balaji HD; Hariharan S; Jacob CK; Kirubakaran MG; Shastry JC
    J Assoc Physicians India; 1988 Nov; 36(11):677-8. PubMed ID: 3074079
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial.
    Johansen KL; Painter PL; Sakkas GK; Gordon P; Doyle J; Shubert T
    J Am Soc Nephrol; 2006 Aug; 17(8):2307-14. PubMed ID: 16825332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional effect of nandrolone decanoate in predialysis patients with chronic kidney disease.
    Eiam-Ong S; Buranaosot S; Eiam-Ong S; Wathanavaha A; Pansin P
    J Ren Nutr; 2007 May; 17(3):173-8. PubMed ID: 17462549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.